TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online February 5, 1999
TCL Archive Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds August 26, 2005
